Drugs by condition
Drugs approved for multiple sclerosis
Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
40
Still marketed, NDA or BLA
Drug classes
13
Novel drugs
21
New molecular entities and new biologics
In development
30
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for multiple sclerosis.
- Ocrevus Zunovo (Ocrelizumab and Hyaluronidase-Ocsq) · Genentech INC Sep 13, 2024
- Tyruko (Natalizumab-Sztn) · Sandoz INC Aug 24, 2023
- Briumvi (Ublituximab-Xiiy) · Tg Therapeutics, INC NovelDec 28, 2022
- Tascenso Odt (Fingolimod Lauryl Sulfate) · Cycle Dec 9, 2022
- Fleqsuvy (Baclofen) · Azurity Feb 4, 2022
All approved drugs for multiple sclerosis, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 170 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
CD20-directed Cytolytic Antibody (4)
- Briumvi Ublituximab-Xiiy · Tg Therapeutics, INC · 2022
- Ocrevus Ocrelizumab · Genentech INC · 2017
- Kesimpta Ofatumumab · Novartis · 2009
- Ocrevus Zunovo Ocrelizumab and Hyaluronidase-Ocsq · Genentech INC · 2024
gamma-Aminobutyric Acid-ergic Agonist (4)
Interferon beta (3)
Corticosteroid (3)
- Medrol Methylprednisolone · Pfizer · 1957
- Kenalog-40 Triamcinolone Acetonide · Apothecon · 1965
- Cortef Hydrocortisone · Pharmacia and Upjohn · 1952
Sphingosine 1-phosphate Receptor Modulator (2)
Integrin Receptor Antagonist (2)
Adrenocorticotropic Hormone (2)
- Purified Cortrophin Gel Corticotropin · Ani Pharms · 1954
- Acthar Gel Corticotropin · Mallinckrodt Ireland · 1952
Pyrimidine Synthesis Inhibitor (1)
- Aubagio Teriflunomide · Sanofi Aventis US · 2012
Potassium Channel Blocker (1)
- Ampyra Dalfampridine · Merz · 2010
CD52-directed Cytolytic Antibody (1)
- Lemtrada Alemtuzumab · Genzyme · 2001
Acetylcholine Release Inhibitor (1)
- Botox Cosmetic Onabotulinumtoxina · Allergan · 1991
Purine Antimetabolite (1)
- Mavenclad Cladribine · Emd Serono INC · 2019
Class not listed in FDA's data (15)
- Zeposia Ozanimod Hydrochloride · Bristol · 2020
- Tecfidera Dimethyl Fumarate · Biogen · 2013
- Gilenya Fingolimod Hydrochloride · Novartis · 2010
- Copaxone Glatiramer Acetate · Teva Pharms USA · 1996
- Betaseron Interferon Beta-1b · Bayer Healthcare Pharms · 1993
- Dantrium Dantrolene Sodium · Ph Health · 1974
- Celestone Soluspan Betamethasone Acetate, Betamethasone Sodium Phosphate · Organon · 1965
- Tascenso Odt Fingolimod Lauryl Sulfate · Cycle · 2022
- Bafiertam Monomethyl Fumarate · Banner Life Sciences · 2020
- Vumerity Diroximel Fumarate · Biogen · 2019
- Orapred Odt Prednisolone Sodium Phosphate · Advanz Pharma · 2006
- Pediapred Prednisolone Sodium Phosphate · Pai Holdings · 1986
- Depo-Medrol Methylprednisolone Acetate · Pfizer · 1959
- Solu-Medrol Methylprednisolone Sodium Succinate · Pharmacia and Upjohn · 1959
- Solu-Cortef Hydrocortisone Sodium Succinate · Pharmacia and Upjohn · 1955
Drugs in development for multiple sclerosis
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- OrelabrutinibICP-022Phase 311 trials
Beijing InnoCare Pharma Tech Co., Ltd. · Mantle Cell Lymphoma, Part 1:r/r B-cell Malignancies, Part 2:B-cell Malignancies
- FrexalimabSAR441344Phase 39 trials
Sanofi · Multiple Sclerosis, Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion
- FenebrutinibRO7010939, GDC-0853Phase 36 trials
Roche (Genentech) · Relapsing Multiple Sclerosis, Multiple Sclerosis, Multiple Sclerosis, Primary Progressive
- PPV2323-valent Pneumococcal Polysaccharide Vaccine, lot 1Phase 36 trials
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd · Healthy Volunteers, Streptococcus Pneumoniae Infection, Pneumococcal Disease
- RocbrutinibLP-168, NWP-775Phase 36 trials
Guangzhou Lupeng Pharmaceutical Company LTD. · Diffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL), Mantle Cell Lymphoma
- rHuPH20Phase 35 trials
Bristol Myers Squibb · Melanoma, Relapsing-remitting Multiple Sclerosis, Clear Cell Renal Cell Carcinoma
- ObexelimabPhase 34 trials
Zenas BioPharma (USA), LLC · Systemic Lupus Erythematosus, Warm Autoimmune Hemolytic Anemia, Relapsing Multiple Sclerosis
- IMU-838Vidofludimus calciumPhase 33 trials
Immunic AG · Relapsing-Remitting Multiple Sclerosis (RRMS), Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting
- MRI contrast-enhancing agentsPhase 33 trials
Sanofi · Multiple Sclerosis
- TolebrutinibSAR442168Phase 33 trials
Sanofi · Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis
- KYV-101Phase 32 trials
Kyverna Therapeutics · Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis
- MRI contrast-enhancing preparationsPhase 32 trials
Sanofi · Multiple Sclerosis
- ABP 692Phase 31 trial
Amgen · Relapsing-remitting Multiple Sclerosis (RRMS)
- BCD-281Phase 31 trial
Biocad · Relapsing-remitting Multiple Sclerosis (RRMS)
- rapcabtagene autoleucelYTB323Phase 28 trials
Novartis · Lupus Nephritis, Rheumatoid Arthritis (RA) and Sjögren's Disease (SjD), ANCA Associated Vasculitis (AAV)
- zamtocabtagene autoleucelMB-CART2019.1Phase 25 trials
Miltenyi Biomedicine GmbH · CAR T Cell Therapy, Mantle Cell Lymphoma (MCL), Multiple Sclerosis
- Allogeneic umbilical cord mesenchymal stem cellsPhase 23 trials
Ever Supreme Bio Technology Co., Ltd. · COVID-19 Infection, Multiple Sclerosis, ST Elevation Myocardial Infarction
- Zugocabtagene geleucelCTX112Phase 23 trials
CRISPR Therapeutics AG · B-cell Lymphoma, Non-Hodgkin Lymphoma, B-cell Malignancy
- Autologous HB-adMSCsPhase 22 trials
Hope Biosciences LLC · Traumatic Brain Injury, Relapsing Remitting Multiple Sclerosis (RRMS), Multiple Sclerosis
- BMS-986368CC-97489Phase 22 trials
Bristol Myers Squibb · Agitation, Alzheimer Disease, Multiple Sclerosis Spasticity
More on multiple sclerosis: recruiting trials · published research
Related in neurology: Alzheimer's disease · Parkinson's disease · Epilepsy and seizures · Migraine · ALS (amyotrophic lateral sclerosis) · Myasthenia gravis · Spinal muscular atrophy · Duchenne muscular dystrophy · Huntington's disease chorea · Tardive dyskinesia
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.